Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,344,097
-$223,553 QoQ
Shares Held
55,818
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,151
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. PFE ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
This page
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,344,097 | 55,818 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $1,567,650 | 55,828 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $1,428,239 | 57,359 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $1,342,540 | 52,690 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $1,438,570 | 59,347 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $1,565,884 | 61,795 | Shares | Defined | 2025-04-07 | |
| 2024-12-31 | $1,133,785 | 42,736 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $1,171,577 | 40,483 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $1,230,503 | 43,978 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $1,282,993 | 46,234 | Shares | Defined | 2024-04-08 | |
| 2023-12-31 | $1,251,932 | 43,485 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $1,301,457 | 39,236 | Shares | Defined | 2023-11-21 | |
| 2023-06-30 | $1,380,708 | 37,642 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $1,623,105 | 39,782 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $2,071,120 | 40,420 | Shares | Defined | 2023-01-06 | |
| 2022-09-30 | $1,806,018 | 41,271 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $1,962,035 | 37,422 | Shares | Defined | 2022-07-14 | |
| 2022-03-31 | $2,259,656 | 43,648 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,130,630 | 19,147 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $838,695 | 19,500 | Shares | Sole | 2021-10-22 | |
| 2021-03-31 | $757,025 | 20,895 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $772,052 | 20,974 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $868,504 | 23,665 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $773,846 | 23,665 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $630,473 | 19,316 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||